ResearcherUniversity of California, BerkeleyNo recent work listed

Dan He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9544-5672; OpenAlex author ID A5007835296. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Co-author DOI 10.1016/j.molcel.2022.06.005 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Craig J. Thomas · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Iok In Christine Chio · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Michael D. Kluger · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Michael Anthony Hollingsworth · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗
Paul M. Grandgenett · 1 shared paper, 2022 · strength 0.12
- Paper Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. DOI 10.1016/j.molcel.2022.06.005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.